Popular product application

Cancer is a serious disease caused by the unrestricted proliferation of cells in the body that lose normal growth control. It can occur in any part of the body, such as the lungs, breasts, colon, and skin. Cancer is one of the major threats to global health, causing millions of deaths each year and bringing profound pain and economic burdens to patients and their families. In recent years, there has been significant progress in the field of cancer treatment, especially in areas such as targeted therapy and immunotherapy. Researchers are working hard to discover new biomarkers and treatment methods to further improve treatment effectiveness.

In this critical field, our company can provide comprehensive solutions to support the research and development of anti-cancer drugs . We have a variety of inhibitors and activators targeting popular oncological targets, such as KRAS inhibitors (MRTX1133, BI-2493, Sotorasib), ferroptosis inhibitors (Ferrostatin-1, iFSP1, Deferoxamine, Mesylate), and ferroptosis activators (Erastin, FIN56, Sorafenib), etc. We also offer a wide range of specialized compound libraries covering a broad spectrum of chemical structures and biological activities to support the discovery and screening process of anti-cancer drugs, such as anti-cancer drug library, ferroptosis compound library, Epigenetics Compound Library, DNA damage & repair compound library, etc. In addition, we provide anti-cancer drug screening services, including virtual screening, molecular docking, and active screening of physical compounds. Combining advanced technology and extensive experience, we can help researchers effectively identify and optimize potential anti-cancer drug candidates